Identification of Subunit- and Antagonist-Specific Amino Acid Residues in theN-Methyl-d-aspartate Receptor Glutamate-Binding Pocket
- 2 March 2005
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Journal of Pharmacology and Experimental Therapeutics
- Vol. 313 (3), 1066-1074
- https://doi.org/10.1124/jpet.104.082990
Abstract
The resolved X-ray crystal structures of the glutamate-binding domain (S1/S2 domains) of the GluR2 and NR1 glutamate receptor subunits were used to model the homologous regions of the N-methyl-d-aspartate (NMDA) receptor's NR2 subunits. To test the predictive value of these models, all four stereoisomers of the antagonist 1-(phenanthren-2-carbonyl) piperazine-2,3-dicarboxylic acid (PPDA) were docked into the NR2B glutamate-binding site model. This analysis suggested an affinity order for the PPDA isomers of d-cis > l-cis > l-trans = d-trans and predicted that the 2-position carboxylate group of the cis-PPDA isomers, but not of the trans-PPDA isomers, may be interacting with histidine 486 in NR2B. Consistent with these predictions, cis-PPDA displays a 35-fold higher affinity for NR2B-containing NMDA receptors than trans-PPDA. In addition, mutating NR2B's H486 to phenylalanine decreased cis-PPDA affinity 8-fold but had no effect on trans-PPDA affinity. In contrast, the NR2B H486F mutation increased the affinity of the typical antagonists CGS-19755 [(2R*,4S*)-4-phosphonomethyl-2-piperidine carboxylic acid] and 4-(3-phosphonopropyl) piperidine-2-carboxylic acid. In the NR1-based NR2 models, there were only four subunit-specific amino acid residues exposed to the ligand-binding pocket (and six in the GluR2-based models). These residues are located at the edge of the binding pocket, suggesting that large antagonists may be necessary for subtype specificity. Of these residues, mutational analysis and modeling suggest that A414, R712, and G713 (NR2B numbering) may be especially useful for developing NR2C- and NR2D-selective NMDA receptor antagonists and that residues A414 and T428 may determine subunit variations in agonist affinity.Keywords
This publication has 36 references indexed in Scilit:
- 5-Phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor compositionBioorganic & Medicinal Chemistry Letters, 2002
- Mechanisms for Activation and Antagonism of an AMPA-Sensitive Glutamate ReceptorNeuron, 2000
- Structure of a glutamate-receptor ligand-binding core in complex with kainateNature, 1998
- Identification of Amino Acid Residues of the NR2A Subunit That Control Glutamate Potency in Recombinant NR1/NR2A NMDA ReceptorsJournal of Neuroscience, 1998
- Pharmacological heterogeneity of NMDA receptors: characterization of NR1a/NR2D heteromers expressed in Xenopus oocytesEuropean Journal of Pharmacology, 1997
- Structure-activity relationships of competitive NMDA receptor antagonistsEuropean Journal of Pharmacology, 1996
- The molecular basis of NMDA receptor subtypes: native receptor diversity is predicted by subunit compositionJournal of Neuroscience, 1994
- Structural requirements for the development of potentBiochemical Pharmacology, 1993
- Identification of a Novel N‐Methyl‐D‐Aspartate Receptor Population in the Rat Medial ThalamusJournal of Neurochemistry, 1992
- Disruption of experience-dependent synaptic modifications in striate cortex by infusion of an NMDA receptor antagonistJournal of Neuroscience, 1990